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Effect of fluid and sodium removal on mortality in peritoneal by many factors, including age, race, the presence of
dialysis patients. comorbid conditions such as diabetes mellitus and car-
Background. Adequacy of peritoneal dialysis (PD) tradition- diovascular disease, nutritional status, serum albumin
ally is assessed using Kt/Vurea and total creatinine clearance level, small solute clearance, and peritoneal membrane(TCC). However, this approach underestimates the importance
transport property [5–15].of fluid and sodium removal. The aim of this study was to
determine the effect of fluid and sodium removal on morbidity Several groups have studied on the importance of
and mortality in PD patients. small solute clearance using Kt/Vurea and total creatinine
Methods. One hundred twenty-five PD patients were moni- clearance (TCC) to predict morbidity and mortality
tored for three years from the beginning of the treatment. The of PD patients. Although there are some conflicting re-effects of demographic features, comorbidity, peritonitis rate,
sults [16], an association between small solute clearanceblood pressure, medications, blood biochemistry, peritoneal
and clinical outcome has been found in these studiesmembrane transport characteristics, residual renal function
(RRF), Kt/Vurea, TCC, normalized protein nitrogen appearance [10–12, 14, 17–21]. These findings have resulted in the
(nPNA), and removal of sodium and fluid on mortality were prescription of an adequate dose of treatment based
evaluated. Total and cardiovascular hospitalization rates were on urea and creatinine kinetics. Regarding the studies
also recorded. A Cox proportional hazards model was used to
indicating cardiovascular disease is the most commondetermine factors predicting mortality.
cause of death in PD patients [1–4], it is difficult toResults. In the Cox model, comorbidity, total sodium and
explain the influence of small solute clearance on cardio-fluid removals, hypertensive status, serum creatinine, and RRF
were independent factors affecting survival. In contrast, Kt/ vascular events. One explanation for this association
Vurea or TCC did not affect the adjusted survivals. Total sodium might be fluid and sodium balance, which might have a
and fluid removal and hypertensive status also significantly direct effect on cardiovascular mortality. Nevertheless,influenced the hospitalization rate. Systolic and diastolic blood
excess fluid and sodium as potential risk factors for pa-pressures were negatively correlated with total fluid (P 0.001)
tient morbidity and mortality to our knowledge has notand sodium removal (P  0.001).
Conclusions. Together, these findings suggest that removal been assessed in prognostic studies. It has been suggested
of sodium and fluid is a predictor of mortality in PD patients, that PD permits more effective management of fluid
whereas Kt/Vurea and TCC are not factors. Adequate fluid and overload and hypertension than hemodialysis (HD) [22].
sodium balance is crucial for the management of patients on PD.
However, compelling evidence exists that PD patients
have a greater fluid overload than HD patients [23, 24].
Therefore, adequate fluid and sodium balance may be
Mortality in patients with end-stage renal disease crucial for the management of patients on PD with re-
(ESRD) is 10 to 20 times higher than that in the age- gard to the prevention of cardiovascular disease.
matched general population [1, 2], cardiovascular disease The purpose of this study was to identify the factors
being the most frequent cause of death [1–4]. The clinical that predict mortality in our PD population during a three-
outcome of peritoneal dialysis (PD) patients is affected year follow-up period. In addition, we tried to determine
the effect of adequacy of fluid and sodium removal on
clinical outcome.Key words: end-stage renal disease, dialysis, death, hospitalization,
hypertension, serum creatinine, residual renal function, Kt/Vurea, creati-
nine clearance, high peritoneal transport.
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monitored from the day of starting PD therapy for three (PET) [26]. Patients were classified as a high transporter
when the ratio of dialysate/plasma (D/P) creatinine atyears. All patients had started their PD treatment be-
tween 1992 and 1996. One hundred sixteen of the pa- the fourth hour was higher than the mean value plus
one standard deviation, and as a low transporter whentients were on CAPD, and the rest were on automatic PD
(APD). The mean age at the start of the treatment was the D/P creatinine ratio was lower than the mean value
minus one standard deviation. The 24-hour dialysate and46.3  14.8 years (range 18 to 74 years). The cause of
ESRD was chronic tubulointerstitial nephritis in 37 cases, urine samples were collected to calculate RRF, Kt/Vurea,
TCC, nPNA, and total sodium removal. RRF was de-chronic glomerulonephritis in 34, diabetic nephropathy
in 13, renal amyloidosis in 11, autosomal dominant poly- fined as the mean of renal urea nitrogen and creatinine
clearances. Weekly TCC was determined by adding thecyctic kidney disease in 8, hypertensive nephrosclerosis
in 7, and unknown in 15 cases. All were dialyzed with RRF to the peritoneal creatinine clearance. Total body
water was calculated by the formulae of Watson, Watsona glucose dialysate containing 132 mmol/L sodium. A
prescription of 24-hour dialysate volume was always per- and Batt [27]. Protein nitrogen appearance was calcu-
lated according to Bergstro¨m et al and was normalizedformed according to the clinical and biochemical status
to avoid uremic symptomatology and to achieve an ade- to the actual body weight (nPNA) [28]. Total sodium
removal was estimated as the sum of the renal and dia-quate control of extracellular fluid volume. The median
instilled dialysate volume on PD was 8.0 L/24 hours (range lytic sodium losses. The amount of daily dialytic sodium
removal was calculated by:of 4.0 to 11.2 L/24 hours), with a mean glucose concentra-
tion of 2.14%.
(Vdr  Cdr)  (Vin  Cin)After the training period of three weeks, all patients
were regularly examined at an outpatient clinic every two where Vdr represents the volume of the drained dialysate
(L/24 hours), Cdr the sodium concentration of the drainedmonths. Data recorded for each patient included demo-
graphic features, comorbidity, blood pressure, medica- dialysate (mmol/L), Vin is the volume of the instilled
dialysate (L/24 hours), and Cin is the sodium concentra-tions, blood biochemistry, peritoneal membrane transport
characteristics, residual renal function (RRF), kinetic tion of the instilled dialysate (mmol/L). RRF, TCC, and
total sodium removal were normalized to 1.73 m2 BSA.indices of dialysis adequacy, and nutritional status such
as Kt/Vurea, TCC and normalized protein nitrogen ap- The first kinetic analysis was done following the comple-
tion of training of CAPD, that is, within 3 months ofpearance (nPNA), renal, dialytic, and total sodium and
fluid removals, peritonitis rate, total and cardiovascular commencing treatment and then repeated every 6 to 12
months. All measurements obtained during the follow-hospitalization rates, and mortality.
Comorbid conditions, including diabetes mellitus, up were averaged for each patient. Total fluid removal
was estimated as urine volume plus peritoneal ultrafil-amyloidosis, hypertensive nephrosclerosis, cardiovascu-
lar disease, and chronic liver disease present at the start tration, determined as the means of seven daily urine
volume and net peritoneal ultrafiltration rates as notedof dialysis, were scored. Each disease was given a value of
two. If two diseases were present, this value was squared, by the patient the week before the routine visits, and
was normalized to 1.73 m2 BSA.and if three were present, this value was cubed [17].
Height and weight were measured with the patient wear-
Statistical analysising indoor clothing before intraperitoneal dialysate at
routine visits. Body mass index (BMI) was calculated by Results are given as mean SD. Comparison of means
and percentages was by the unpaired two-tailed Studentthe formula of [weight (kg)/height (m2)]. Body surface
area (BSA) was estimated from Du Bois nomograms [25]. t test or Mann-Whitney U test, as appropriate, and the
chi-square test with Yates correction. Correlations wereSystolic and diastolic blood pressure levels were mea-
sured at the routine visits. Hypertension was defined as analyzed using Pearson’s or Spearman’s correlation coef-
ficient, as appropriate.systolic blood pressure 140 mm Hg or diastolic blood
pressure 90 mm Hg or taking at least two drugs to Overall patient survival was estimated for each group
with the Kaplan-Meier method, and a comparison ofcontrol blood pressure. The levels of hematocrit, serum
albumin, urea nitrogen, creatinine, sodium, total choles- these outcomes was based on the log rank test. In the
patient’s survival analysis, death was considered as theterol, and triglyceride were measured every two months.
Serum albumin was determined by bromcresol purple final event, and transplantation or transfer to HD was
regarded as censored information. The Cox proportionalmethod. The reference value of the local accredited labo-
ratory was 3.2 to 5.5 g/dL. All the values of arterial blood hazards model was used for the statistical analysis of
patient survival. Death was attributed to the averagepressure and blood biochemistry during the follow-up
were averaged for each patient. levels of the study parameters during the follow-up pe-
riod. The likelihood ratio was used to determine whetherThe transport property of peritoneal membrane was
determined by the standard peritoneal equilibration test the addition of a variable to a model added significantly
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Table 1. Mean values of study parametersto that model. Variables significant at a P value less than
0.02 in univariate analysis were included to a Cox propor- Parameters MeanSD
tional hazards model to assess their independent prog- Body mass index kg/m2 24.64.0
Body surface area m2 1.690.19nostic value for mortality. Only variables significant at
Systolic blood pressure mm Hg 131.317.5a P value of less than 0.05 were kept in the model.
Diastolic blood pressure mm Hg 83.49.8
Initially, the demographic and comorbidity data (age, Hematocrit % 31.14.2
BUN mg/dL 529diabetes mellitus, comorbidity score) were presented to
Serum creatinine mg/dL 10.12.4the model by forward selection (step I). Thereafter, pa-
Serum albumin g/dL 3.50.5
rameters of nutritional status (serum albumin and creati- Sodium mmol/L 1382
Total cholesterol mg/dL 19541nine, and nPNA), hematocrit, and peritonitis rate were
Triglyceride mg/dL 17875added to the model (step II). Next, high peritoneal status,
D/P creatinine 0.660.11
RRF, and the indices of dialysis adequacy (Kt/Vurea and RRF mL/min/1.73 m2 1.211.36
Urine volume mL/24 h/1.73 m2 364525TCC) were presented to the model (step III). Kt/Vurea
Dialytic fluid removal mL/24 h/1.73 m2 1302657and TCC were each added separately to this model,
Total fluid removal mL/24 h/1.73 m2 1666685
and their corresponding peritoneal component was also Renal sodium removal mmol/24 h/1.73 m2 1826
Dialytic sodium removal mmol/24 h/1.73 m2 16780added separately to the model at the same time. Finally,
Total sodium removal mmol/24 h/1.73 m2 18578total sodium and fluid removal and hypertensive status
Weekly total Kt/Vurea 2.030.33were each presented separately to the model (step IV). Weekly dialytic Kt/Vurea 1.780.29
Total creatinine clearance L/week/1.73 m2 62.311.9This procedure was repeated with a backward selection
Dialytic creatinine clearance L/week/1.73 m2 51.29.3strategy, and the results of both strategies were com-
nPNA g/kg/24 h 1.010.19
pared. The independent prognostic values of the vari- Peritonitis rate episodes/patient-year 0.570.50
Total hospitalization days/patient-year 18.420.4ables were expressed as adjusted relative risks (RR) with
Cardiovascular hospitalization days/patient-year 7.210.8their 95% confidence intervals (CIs).
Abbreviations are: BUN, blood urea nitrogen; D/P, dialysate/plasma; RRF,
residual renal function; nPNA, normalized protein nitrogen appearance.
The averaged value of the study parameters during the follow-up period wereRESULTS used for each patient.
The total follow-up period was 319 patient-years, with
a mean of 30.6 months (range, 7 to 40 months). Twenty-
two patients died (20.8%) during the three-year follow-
correlated with high peritoneal transport status (r up period. Causes of death were cardiovascular disease
0.25, P  0.01).in 11 patients (50.0%), infection in 6, malnutrition in 2,
Both the total and cardiovascular hospitalization ratesand gastrointestinal bleeding, colonic perforation, and
were significantly higher in patients who had a total so-unknown in 1 patient each. During the follow-up period,
dium removal below the median value than those of the5 patients received a kidney transplant, while 18 patients
others (24.9  22.4 vs. 11.9  15.8 days/patient-year,were transferred to HD, 5 of whom for ultrafiltration
respectively, P  0.001 for total hospitalization, andfailure. Two- and three-year patient survival rates were
10.1  12.7 vs. 4.2  7.6 days/patient-year, respectively,86.3 and 79.2%, respectively. Mean values of the study
P  0.01 for cardiovascular hospitalization).parameters during the follow-up period are shown in
Patients were classified into four groups according toTable 1. There was one comorbid condition in 39 patients
total sodium removal: group I, total sodium removal be-at the time of the initiation of PD, 2 in 13 patients, and
low the 25th percentile value (130 mmol/24 h/1.73 m2);3 in 1 patient. The mean comorbidity score was 1.1 1.3.
group II, total sodium removal between the 25th and
Sodium removal 50th percentile values (130 to 181 mmol/24 h/1.73 m2);
group III, total sodium removal between 50th and 75thThe mean total sodium removal was 185  78 mmol/
percentile values (181 to 232 mmol/24 h/1.73 m2); and24 h/1.73 m2, and the median value was 181 mmol/24
group IV, total sodium removal above the 75th percentileh/1.73 m2. The contribution of renal component to total
value (232 mmol/24 h/1.73 m2). The three-year patientsodium removal was 9.7%. Although dialytic sodium re-
survival rates were significantly different among thesemoval was higher in CAPD patients (170  80 mmol/
groups (group I, 59.3%; group II, 73.1%; group III,24 h/1.73 m2) than that of APD patients (130 78 mmol/
88.9%; and group IV, 96.1%, P  0.01; Fig. 1).24 h/1.73 m2), the difference did not reach a statistically
significant level (P  0.05). There was a strong corre-
Fluid removallation between peritoneal sodium and fluid removal
The mean renal, dialytic, and total fluid removals were(r  0.83, P  0.001). Total sodium removal was also
364  525, 1302  657, and 1666  685 mL/24 h/1.73 m2,positively correlated with total Kt/Vurea (r  0.42, P 
0.001) and TCC (r  0.29, P  0.001), and negatively respectively. The contribution of urine volume to total
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Fig. 1. Three-year patient survival rates in
peritoneal dialysis (PD) patients according to
the total sodium removal. The four groups are
defined as: group I, 130 mmol/24 h/1.73 m2;
group II, 130 to 181 mmol/24 h/1.73 m2; group
III, 181 to 232 mmol/24 h/1.73 m2; and group
IV, 232 mmol/24 h/1.73 m2.
fluid removal was 21.8%. Total fluid removal was nega- diastolic blood pressure levels (r  0.42, P  0.001)
and the use of antihypertensive drugs (r  0.56, P tively correlated with high transport status (r  0.39,
P  0.001). The total and cardiovascular hospitalization 0.001). There also were statistically significant correla-
tions between total fluid removal and both systolic (r rates were significantly higher in patients who had a total
fluid removal scores below the median value (1570 mL/ 0.48, P  0.001), and diastolic blood pressures (r 
0.39, P  0.001). Total sodium removal, total fluid24 h/1.73m2) than those scoring above the median (25.2
23.4 vs. 11.6  14.0 days/patient year, respectively, removal, urine volume, Kt/Vurea, TCC, and serum albu-
min were significantly lower in hypertensive patientsP  0.001 for total hospitalization, and 11.4  13.7 vs.
2.9  4.1 days/patient year, respectively, P  0.001 for than those in normotensives (Table 2). Total and cardio-
vascular hospitalization rates were significantly highercardiovascular hospitalization).
Patients were classified into four groups according to in patients with hypertension (P  0.001 and P  0.01,
respectively).total fluid removal: group I, total fluid removal below
the 25th percentile (1265 mL/24 h/1.73 m2); group II,
Peritoneal transport characteristicstotal fluid removal between the 25th and 50th percentiles
(1265 to 1570 mL/24 h/1.73 m2); group III, total fluid The mean D/P creatinine ratio was 0.66 0.11. Fifteen
removal between the 50th and 75th percentiles (1570 to patients (12.0%) were classified as high transporters, and
2035 mL/24 h/1.73 m2); and group IV, total fluid removal 19 (15.2%) were classified as low transporters according
above the 75th percentile (2035 mL/24 h/1.73 m2). The to the PET scores. Total and peritoneal sodium removal,
three-year patient survival rates were different among total and peritoneal fluid removal, Kt/Vurea, serum albu-
these groups (group I, 61.5%; group II, 71.4%; group min, and creatinine were significantly lower in high trans-
III, 88.0%; and group IV, 96.3%, P  0.01; Fig. 2). porters than those of the average or low transporters
(P  0.01, P  0.01, P  0.05, P  0.001, and P  0.05,
Blood pressure respectively; Table 3). The TCC and nPNA were not
different between the groups. In high transporters, sys-The mean blood pressure level was 131.3 17.4/83.4
9.8 mm Hg. Forty-nine patients (39.2%) were hyperten- tolic blood pressure was significantly higher compared
to the average or low transporters (P  0.05). Amongsive. The three-year patient survival rate was significantly
worse in hypertensive patients compared to that of nor- the high transporters, the prevalence of hypertension
was significantly higher than the other groups (66.7 vs.motensives (60.5 vs. 92.1%, respectively, P  0.0001).
The total sodium removal was found to be negatively 35.5%, respectively, P  0.05). The rates of total and
cardiovascular hospitalization were significantly highercorrelated with systolic (r  0.49, P  0.001), and
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Fig. 2. Three-year patient survival rates in PD
patients according to total fluid removal. The
four groups are defined as: group I,1265 mL/
24 h/1.73 m2; group II, 1265 to 1570 mL/24
h/1.73 m2; group III, 1570 to 2035 mL/24 h/1.73
m2; and group IV, 2035 mL/24 h/1.73 m2.
Table 2. Comparison of the study parameters between hypertensive and normotensive patients
Hypertensives Normotensives P
Body mass index kg/m2 25.13.7 23.84.3 0.07
Total sodium removal
mmol/24 h/1.73 m2 13660 21870 0.001
Total fluid removal
mL/24 h/1.73 m2 1353570 1875679 0.001
Urine volume mL/24 h/1.73 m2 245420 443573 0.05
RRF mL/min/1.73 m2 0.931.27 1.381.40 0.07
Weekly total Kt/Vurea 1.920.28 2.100.35 0.01
TCC L/week/1.73 m2 59.011.9 64.511.4 0.01
nPNA g/kg/24 h 0.990.17 1.030.21 NS
Serum albumin g/dL 3.320.45 3.640.46 0.001
Total hospitalization days/patient-year 25.622.6 13.717.3 0.001
Cardiovascular hospitalization days/patient-year 10.512.4 5.09.0 0.01
Abbreviations are: RRF, residual renal function; TCC, total creatinine clearance; nPNA, normalized protein nitrogen appearance; NS, not significant.
in high transporters than the other groups (P 0.01 and survivors, although the differences did not reach statisti-
P  0.001, respectively). cal significance (P  0.05).
Seven of the high transporters died during the follow-
up period. The three-year survival rate was significantly Small solute clearances
worse in high transporters compared with both average The mean values of Kt/Vurea, TCC, and nPNA areand low transporters (46.2, 84.4, and 81.3%, respectively, shown in Table 1. The contribution of renal component
P  0.001). In the high transporters who died during the
on total solute clearance was 12.4% for Kt/Vurea andfollow-up, the baseline comorbidity score was signifi-
17.7% for TCC. The three-year survival rate was signifi-cantly higher than those of the surviving high transport-
cantly higher in patients who had a Kt/Vurea value aboveers and patients with other transport status (3.43  0.98,
2.0 (88.5 vs. 70.4%, respectively, P  0.05), a TCC value1.00  1.07, and 0.93  1.26, respectively, P  0.01).
above 60.0 L/week/1.73m2 (87.7 vs. 69.4%, respectively,These patients had also less RRF (0.73  0.39 vs. 1.24 
P  0.05), or an nPNA value above 1.0 g/kg/24 h (89.41.12 mL/min/1.73 m2), and total (109  55 vs. 154  68
vs. 71.2%, respectively, P 0.05) than the other patientsmmol/24 h/1.73 m2) and dialytic sodium removal (98 
51 vs. 133  61 mmol/24 h/1.73 m2) than those of the with lower values.
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Table 4. Relative risk of death (RR) of study parameters inTable 3. Comparison of the study parameters according to
peritoneal transport characteristics of the patients univariate Cox regression
RR 95% CI PHigh Other
transporters patients P
Age 1 year 1.04 1.01–1.07 0.05
Sex male 1.36 0.58–3.18 NSBUN mg/dL 5010 5310 NS
Serum creatinine mg/dL 8.72.6 10.32.4 0.05 Body mass index 1 kg/m2 1.02 0.88–1.10 NS
Diabetes mellitus present 3.54 1.38–9.06 0.01Serum albumin g/dL 3.10.5 3.60.4 0.001
Systolic blood pressure Comorbidity score 1 point 1.97 1.47–2.63 0.0001
1 comorbid condition 6.01 1.68–21.57 0.01mm Hg 139.911.5 130.117.2 0.05
Diastolic blood pressure 2 comorbid conditions 17.64 4.63–67.28 0.0001
Peritonitis rate 1 episode/patient-year 3.63 1.54–8.52 0.01mm Hg 86.46.3 83.09.4 NS
Dialytic fluid removal Systolic blood pressure 10 mm Hg 1.64 1.22–2.21 0.01
Diastolic blood pressure 10 mm Hg 1.70 1.10–2.61 0.05mL/24 h/1.73 m2 876730 1361628 0.01
Total fluid removal Hypertension present 6.01 2.21–16.32 0.001
Use of antihypertensive drugsmL/24 h/1.73 m2 1186687 1732661 0.01
Dialytic sodium removal 1 drug 4.88 1.63–14.57 0.01
2 drugs 9.25 3.01–28.47 0.0001mmol/24 h/1.73 m2 11758 17480 0.01
Total sodium removal Hematocrit 1% 0.86 0.77–0.97 0.05
BUN 1 mg/dL 0.95 0.91–1.01 NSmmol/24 h/1.73 m2 13364 19277 0.01
RRF mL/min/1.73 m2 1.000.82 1.231.42 NS Serum creatinine 1 mg/dL 0.54 0.41–0.71 0.0001
Serum albumin 0.1 g/dL 0.85 0.79–0.92 0.0001Weekly total Kt/Vurea 1.870.29 2.050.33 0.05
TCC L/week/1.73 m2 64.29.1 62.012.2 NS Total cholesterol 10 mg/dL 0.90 0.81–1.01 NS
Triglyceride 10 mg/dL 0.95 0.90–1.01 NSnPNA g/kg/24 h 0.960.21 1.020.19 NS
Total hospitalization Instilled dialysate volume
100 mL/24 h/1.73 m2 1.00 0.97–1.04 NSdays/patient-year 31.531.2 16.717.9 0.01
Cardiovascular hospitalization RRF 1 mL/min/1.73 m2 0.59 0.36–0.98 0.05
High transporter status present 4.73 1.92–11.66 0.001days/patient-year 17.019.3 5.88.5 0.001
Kt/Vurea 0.1 unit/week 0.79 0.65–0.96 0.05Abbreviations are: BUN, blood urea nitrogen; RRF, residual renal function;
TCC 1 L/week/1.73 m2 0.94 0.90–0.99 0.05TCC, total creatinine clearance; nPNA, normalized protein nitrogen appearance;
nPNA 0.1 g/kg/24 h 0.67 0.49–0.90 0.01NS, not significant.
Urine output 100 mL/24 h/1.73 m2 0.97 0.95–0.99 0.05
Dialytic fluid removal
100 mL/24 h/1.73 m2 0.89 0.83–0.96 0.01
Total fluid removalCox proportional hazards model 100 mL/24 h/1.73 m2 0.88 0.83–0.95 0.001
Renal sodium removalThe relative risks (RRs) of death associated with the
1 mmol/24 h/1.73 m2 0.97 0.95–1.01 NSstudy parameters are shown in Table 4. The following Dialytic sodium removal
variables reached statistically significant levels in univari- 10 mmol/24 h/1.73 m2 0.88 0.83–0.94 0.001
Total sodium removalate analysis and were included in the Cox model: age,
10 mmol/24 h/1.73 m2 0.86 0.80–0.92 0.0001diabetes mellitus, comorbidity score, serum creatinine
Abbreviations are: BUN, blood urea nitrogen; RRF, residual renal function;and albumin, nPNA, hematocrit, peritonitis rate, high TCC, total creatinine clearance; nPNA, normalized protein nitrogen appearance;
NS, not significant.transporter status, RRF, Kt/Vurea, TCC, total sodium re-
moval, total fluid removal, and hypertensive status.
Table 5 presents the Cox model at each step until the
final model. The final Cox proportional hazards model
DISCUSSIONfor patient survival obtained by forward and backward
Dialysis prolongs the life of patients with ESRD byselection was identical. Tables 6, 7, and 8 show the final
the removal of excess fluid and waste products. Despitemodels containing total sodium removal, total fluid re-
this therapy, mortality in this population is 10 to 20 timesmoval, and hypertension, respectively. Comorbidity, se-
higher than in the age-matched general population [1, 2].rum creatinine, RRF, total sodium removal, total fluid
Several studies have shown that insufficient urea andremoval, and hypertensive status were the predictors
creatinine clearance in PD is associated with increasedof death. Similar results were obtained when dialytic
mortality and morbidity [10–12, 14, 17–21]. The CANUSAcomponents were presented to the model instead of total
study, a prospective, cohort study of 680 new patientssodium and fluid removals [RR  0.91 (95% CI, 0.85 to
treated by PD, provides further information [12]. In that0.98) per 10 mmol/24 h/1.73 m2, P  0.01 for peritoneal
study, following adjustments for demographic factorssodium removal; and RR0.94 (95% CI, 0.90 to 0.99)
such as age, diabetes, cardiovascular disease and serumper 100 mL/24 h/1.73 m2, P  0.05 for peritoneal fluid
albumin, both Kt/Vurea and TCC were shown to predictremoval]. It was estimated that a 10 mmol/24 h/1.73 m2
survival significantly. These findings have lead to a defi-higher value in total sodium removal, and a 100 mL/24
nition of dialysis adequacy by parameters of small soluteh/1.73 m2 higher value in total fluid removal was associ-
removal. However, in view of the finding of many studiesated with a 10% decrease in the RR of death. In contrast,
that cardiovascular disease is the most common causethe total and dialytic components of Kt/Vurea and TCC
were not predictive for death. of death [1–4], accounting for nearly 50% of mortality,
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Table 6. Final multivariate Cox proportional hazards model ofTable 5. Cox proportional hazards model at each step
until final model patient survival using total sodium removal
RR 95% CI PRR 95% CI
Step I Comorbidity score 1 point 1.65 1.19–2.31 0.01
Serum creatinine 1 mg/dL 0.69 0.55–0.87 0.01Age 1 year 1.01 0.97–1.04
Comorbidity score 1 point 1.97 1.47–2.62 RRF 1 mL/min/1.73 m2 0.53 0.31–0.91 0.05
Total sodium removal 10 mmol/24 h/1.73 m2 0.90 0.84–0.96 0.001Diabetes mellitus present 0.73 0.25–2.19
Step II Abbreviations are: RR, relative risk of death; RRF, residual renal function.
Comorbidity score 1 point 1.77 1.31–2.40
Serum albumin 0.1 g/dL 0.93 0.83–1.05
Serum creatinine 1 mg/dL 0.68 0.55–0.83
Table 7. Final multivariate Cox proportional hazards model ofnPNA 0.1 g/kg/24 h 0.79 0.60–1.04
patient survival using total fluid removalHematocrit 1% 0.90 0.79–1.02
Peritonitis rate 1 episode/patient-year 0.94 0.62–1.45 RR 95% CI P
Step III
Comorbidity score 1 point 1.87 1.36–2.58 Comorbidity score 1 point 2.04 1.44–2.90 0.0001
Serum creatinine 1 mg/dL 0.69 0.56–0.86 0.001Serum creatinine 1 mg/dL 0.64 0.50–0.79
High transporter status present 1.07 0.35–3.26 RRF 1 mL/min/1.73 m2 0.41 0.22–0.73 0.01
Total fluid removal 100 mL/24 h/1.73 m2 0.90 0.84–0.96 0.01RRF 1 mL/min/1.73 m2 0.53 0.31–0.92
Small solute clearance Abbreviations are: RR, relative risk of death; RRF, residual renal function.
Total Kt/Vurea 0.1 unit/week 0.90 0.74–1.10
TCC 1 L/week/1.73 m2 0.95 0.89–1.01
Abbreviations are: nPNA, normalized protein nitrogen appearance; RRF, Table 8. Final multivariate Cox proportional hazards model of
residual renal function; TCC, total creatinine clearance; NS, not significant; RR, patient survival using hypertensive status
relative risk of death.
RR 95% CI P
Comorbidity score 1 point 2.20 1.51–3.23 0.0001
Serum creatinine 1 mg/dL 0.74 0.59–0.93 0.01
RRF 1 mL/min/1.73 m2 0.45 0.24–0.83 0.05it is logical to assume that failure to achieve targets of
Hypertension present 5.61 1.97–15.93 0.001adequacy is in some way associated with an increased
Abbreviations are: RR, relative risk of death; RRF, residual renal function.risk of adverse cardiovascular targets. It is difficult to
explain the influence of small solute clearance on cardio-
vascular disease. Harty, Venning and Gokal suggested effect of adequacy of fluid and sodium removal on mor-
that insufficient clearance returns the patients to the pre- tality in PD patients. Both fluid and sodium removal
dialysis uremic milieu and thus increases the likelihood were independent predictors of death in Cox model. A
of cardiac dysfunction [29]. Another possible explanation 10 mmol/24 h/1.73 m2 lower value of total sodium re-
for the association between small solute clearance and moval and a 100 mL/24 h/1.73 m2 lower value of total
cardiovascular mortality may be the relationship of small fluid removal was associated with a 10% increase in the
solute clearance to fluid and sodium balance, which could RR of death. The survival rate, determined with the
have a direct effect on cardiovascular events. Inadequate Kaplan-Meier survival analysis, increased linearly over
fluid and sodium removal as potential risk factors for the entire range of both fluid or sodium removal. More-
patient morbidity and mortality have not yet been assessed over, decreased fluid and sodium removal was associated
in PD patients. Recently, the Netherlands Cooperative with an increased hospitalization rate. Similar to studies
Study on the Adequacy of Dialysis showed that systolic of Jager et al [15] and Kemperman et al [30], hyperten-
blood pressure, as an indicator of fluid overload, is an sive status was found to be a poor prognostic indicator
independent predictor of mortality [15]. However, in in Cox model. Kaplan-Meier survival analysis revealed
that study, total daily fluid removal was not significantly that three-year patient survival rate was significantly
associated with mortality, and the effect of sodium re- lower in hypertensive patients compared to normoten-
moval on patient survival has not been examined. sives. Although the pathophysiology of hypertension in
Although the present study was done with a relatively PD patients is multifactorial, the significant negative cor-
small number of patients, it provides useful data about relations between blood pressures and both fluid and
the prognostic factors in our PD cohort. Particularly, the sodium removal suggest that retention of fluid and so-
center effect on prognosis was excluded, as it was a dium is quite important. The significant association be-
single-center study. Moreover, our patient population tween the use of antihypertensive drugs and mortality
was younger and had less comorbid conditions than that in univariate analysis suggests that the antihypertensive
in other published studies. The incidence of diabetes in medications did not abolish the undesirable effect of the
our study population was less than that in the CANUSA retention of fluid and sodium, and consequently hyper-
study (10.4 vs. 29.7%), indicating that the present study tension on prognosis in dialysis patients. Adequate so-
had a few confounding factors. The most remarkable dium and fluid removal as the treatment for hypertension
instead of antihypertensive drugs seems to be a moreresult of this study was the importance of the predictive
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logical approach. It is speculated that a high fluid and and hypertension decreased significantly in the first three
sodium removal on dialysis is not only an indicator of years, after five years, both of these risk factors were
good volume control, but also may be related to more found with the same prevalence as at the start of CAPD
fluid and sodium intake. However, the negative correla- treatments [35]. This late increase in the frequency of
tions observed between blood pressures and both sodium left ventricular hypertrophy and hypertension probably
and fluid removal in our study suggest that a high fluid reflects the loss of RRF. The adverse impact of loss of
and sodium removal can provide good volume control. RRF on outcome in PD patients could be partly from a
The experience from Tassin, France has shown that ag- difficulty in managing fluid status, hypertension, and left
gressive blood pressure control and normalization of ex- ventricular hypertrophy, all of which contribute to in-
tracellular volume with long slow HD improved the over- creased cardiovascular mortality.
all patient outcome [31]. There is no reason to believe In contrast to what has been suggested in other studies
that this would be different in PD. Therefore, rigorous [13, 14], a high peritoneal transporter status was found to
control of blood pressure and normalization of the extra- be associated with patient survival only in the univariate
cellular volume status should be a part of the definition analysis but not in the multivariate analysis. The cause
of adequacy in PD patients. Despite some hemodynamic of the lack of association between high transport status
advantages of PD, there is compelling evidence that PD and mortality in the multivariate analysis might be that
patients have greater fluid overload than HD. Rottem- the baseline comorbidity score was significantly higher
bourg monitored pulmonary capillary wedge pressures in those high transporters who died compared to other
in CAPD patients and found that they were constantly patients. High transporters have a decreased fluid and
overhydrated [23]. The overhydration is further demon- sodium removal and a higher blood pressure level. More-
strable when CAPD patients are transferred to HD. over, the hospitalization rate was found to be signifi-
Within three months after transfer to HD, significant cantly higher in high transporters. Therefore, aggressive
decreases were observed in body weight and blood pres- control of volume status and blood pressure would help
sure [24]. Two important conclusions can be derived to decrease cardiovascular morbidity and mortality in
from these observations: First, the determination of dry these patients.
weight of PD patients is difficult, unless hemodynamic The validity of small solute clearance for clinical out-
parameters are obtained. Second, there is a serious prob- come in PD patients has been debated, with studies fa-
lem of achieving a normal fluid and sodium balance in voring [10–12, 14, 17–21] or opposing [15, 16] the theory.
the greater portion of PD patients. Indeed, clinical fea- We have not found an independent association between
tures of overhydration are evident in approximately one mortality and either Kt/Vurea or TCC in the Cox model.fourth of the patients undergoing PD [32], and latent
The clearance concept was developed to characterize the
overhydration also is quite frequent in these patients.
quality of a membrane, but not to completely estimateChronic asymptomatic fluid overload would contribute
the removal of waste products. The Kt/V value thereforeto hypertension, and thus left ventricular hypertrophy, a
reflects not only the fractional clearance of urea, butpredictor of mortality in ESRD patients [33, 34], or di-
also the peritoneal permeability and the degree of fluidrectly to cardiac dilation. Excess of fluid is generally ac-
removal. It is recognized that the loss of ultrafiltrationcompanied by excess extracellular sodium. Adequate fluid
due to high peritoneal permeability and declining of RRFand sodium balance therefore is crucial for the manage-
leads to a state of chronic fluid overload. In this situation,ment of patients on PD to prevent cardiovascular disease.
the measured Kt/Vurea is less because the V representsRestricting oral fluid and sodium intake is frequently not
an increased volume of urea distribution caused by in-enough, and compliance is often inadequate, to achieve
creased fluid accumulation. Thus, decreased Kt/Vurea maya neutral fluid and sodium balance. RRF may have an
reflect an increase in volume as opposed to inadequateimportant impact on the ability to deliver adequate fluid
absolute solute removal. The lower values of Kt/Vureaand sodium balance. However, once the RRF is too low
and TCC in hypertensive patients compared with normo-or absent, which generally occurs two years after the ini-
tensives in present study supports this probability. Thetiation of dialysis, control of fluid and sodium retention as
predictive value of Kt/Vurea or TCC on prognosis largelywell as hypertension becomes more difficult. Therefore,
depends upon RRF, but not the dialytic component influid and sodium removal by dialysis may be an impor-
most of the relevant studies [12, 20, 21]. Furthermore,tant approach to reduce the risk of death in PD patients.
no study has shown clearly that a prospective increaseThe present study also demonstrates that RRF has a
in peritoneal clearance leads to improved outcomes.major impact on patient survival. Data from CANUSA
We found that serum creatinine and comorbid condi-demonstrated that the overall outcome was worse for
tions were independent predictors of survival in the Coxpatients who lost their RRF (abstract; Bargman et al,
model. A 1 mg/dL lower value of serum creatinine wasJ Am Soc Nephrol 8:185A, 1997). Lameire reported that
although the prevalence of left ventricular hypertrophy associated with a 30% increase in the RR of death. How-
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The predictive value of the initial clinical and laboratory variables.ever, in contrast to what other studies have suggested
Nephron 65:23–27, 1993
[6, 9, 12, 34], serum albumin was not an independent 10. Genestier S, Hedelin G, Schaffer P, et al: Prognostic factors in
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Dial Transplant 10:1905–1911, 1995relationship between serum albumin and patient survival
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26:353–361, 1995hypoalbuminemia. Our findings suggest that serum cre-
12. Churchill DN, Taylor DW, Keshaviah PR, the Canada-USAatinine may be a better biochemical indicator of progno- (CANUSA) Peritoneal Dialysis Study Group: Adequacy of dialysis
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